As the pace of clinical research continues to accelerate, 2025 marked a year of focused, intentional growth for Tekton Research — particularly in high-demand therapeutic areas like neuroscience and cardiometabolic health. Rather than expanding for expansion’s sake, our work this year centered on strengthening the capabilities that matter most to sponsors, investigators, and patients: faster … Read more
Growth strengthens Tekton’s regional density and enhances access to diverse patient populations AUSTIN, TX – Tekton Research, a leading multi-site clinical trial organization, today announced the addition of two new research sites in New Carlisle, Ohio, and Englewood, New Jersey. The expansion supports Tekton’s continued growth in Neuroscience and General Medicine research while deepening access … Read more
Lennox-Gastaut Syndrome (LGS) is a severe form of epilepsy that typically develops in early childhood and often leads to lifelong challenges. LGS evolves over time, most commonly emerging between ages 1 and 8. While rare, it affects approximately one in every 2,000 individuals (source: LGS Foundation), with about 50,000 people in the United States and … Read more
Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic Research AUSTIN, TX – October 2, 2025 — Tekton Research, a leading multi-site clinical trial company, is pleased to announce the promotion of Corey A. Collins to Chief Executive Officer (CEO). Collins joined Tekton in December 2023 as Chief Financial Officer, bringing over 20 years of … Read more
Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 — Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These additions reflect Tekton’s continued commitment … Read more
When it comes to clinical research, no two studies are exactly alike—but rare disease trials stand in a category of their own. Though each condition may affect only a small number of people, together rare diseases impact an estimated 300 million patients worldwide. For these individuals and families, research often represents the only pathway to … Read more
Alzheimer’s Disease remains one of the most pressing public health challenges of our time. Affecting over 6 million Americans, this progressive neurological disorder not only takes a profound toll on individuals and their families–it also places a significant burden on healthcare systems worldwide. While there is no cure yet, hope is on the horizon–and clinical … Read more
Obesity is more than a number on a scale–it’s a chronic disease that significantly increases the risk of developing long-term health conditions. At Tekton Research, we’re committed to advancing research in obesity because we know it’s at the core of a larger health crisis. Understanding and treating obesity isn’t just about weight loss, it’s about … Read more
Clinical trials are essential to advancing medicine, bringing new therapies from discovery to approval. Traditionally, these trials have been centered in academic institutions and large hospitals—but embedded research site networks like Tekton help make trials accessible within community-based settings, where patients are being treated every day. As a trusted partner in clinical research, Tekton makes … Read more
In today’s healthcare landscape, health literacy is more than a buzzword—it’s a foundational element for equitable, ethical, and effective clinical research. But what does health literacy really mean, and why is it so vital in the research setting? Defining Health Literacy Health literacy refers to a person’s ability to access, understand, and use information to … Read more